The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) Trial

Rebecca Brown Fountain, David R. Holmes, Krishnaswamy Chandrasekaran, Douglas Packer, Samuel Asirvatham, Robert Van Tassel, Zoltan Turi

Research output: Contribution to journalArticle

141 Scopus citations

Abstract

The Protect AF trial is the only randomized trial of a percutaneous LAA isolation device. This trial is focused on evaluation of the relative merits of such a device versus standard therapy with warfarin.

Original languageEnglish (US)
Pages (from-to)956-961
Number of pages6
JournalAmerican heart journal
Volume151
Issue number5
DOIs
StatePublished - May 1 2006

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) Trial'. Together they form a unique fingerprint.

  • Cite this